Showing results (31-40 of 6,269) with videos related to
Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|October 14, 2021
Effects of dipeptidyl peptidase-4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residentsAndrew R Zullo, Matthew S Duprey, Robert J Smith, et al.Diabetes, Obesity & Metabolism|April 13, 2022
Severe iatrogenic hypoglycaemia modulates the fibroblast growth factor protein responseManjula Nandakumar, Abu Saleh Md Moin, Manjunath Ramanjaneya, et al.Diabetes, Obesity & Metabolism|July 25, 2022
Evaluation of continuous glucose monitoring-derived person-specific HbA1c in the presence and absence of complications in type 1 diabetesYongjin Xu, Philippe Oriot, Timothy C Dunn, et al.Diabetes, Obesity & Metabolism|July 27, 2022
Preclinical pharmacology of RA15127343: In vitro and in vivo activity of a novel ultralong-acting basal insulinUlrich Werner, Maximilian Bielohuby, Marcus Korn, et al.Diabetes, Obesity & Metabolism|October 1, 2010
In support of an early polypharmacy approach to the treatment of type 2 diabetesE E Wright, A H Stonehouse, R M CuddihyDiabetes, Obesity & Metabolism|October 1, 2010
Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndromeS Fazio, J R Guyton, J Lin, et al.Diabetes, Obesity & Metabolism|October 1, 2010
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic ratsF R Macdonald, J E Peel, H B Jones, et al.Diabetes, Obesity & Metabolism|July 2, 2010
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetesB W Bode, M A Testa, M Magwire, et al.Diabetes, Obesity & Metabolism|July 2, 2010
A population model evaluating the costs and benefits associated with different oral treatment strategies in people with type 2 diabetesP McEwan, M Evans, K BergenheimDiabetes, Obesity & Metabolism|July 2, 2010
Impact of concurrent macrovascular co-morbidities on healthcare utilization in patients with type 2 diabetes in Europe: a matched studyA Z Fu, Y Qiu, L Radican, et al.Pageof 627